Hepatitis B functional cure with bepirovirsen held in 90% to 92% of responders 48 weeks after stopping all therapy, per data at The Liver Meeting 2026.
|Articles|February 14, 2023
Supplements and Featured Publications
- Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety
Participating Faculty: Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety
Author(s)Steven Yeh, MD, Thomas Ciulla, MD, MBA
Advertisement
Faculty
Steven Yeh, MD
Professor of Ophthalmology & Director of the Retina and Uveitis Service
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, NE
Thomas Ciulla, MD, MBA
Chief Medical Officer & Chief Development Officer
Clearside Biomedical
Alpharetta, GA
Volunteer Clinical Professor
Indiana University School of Medicine
Indianapolis, Indiana
Faculty Disclosures
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Steven Yeh, MD
CONSULTANCIES OR PAID ADVISORY BOARDS
Bausch + Lomb, Adverum Biotechnologies, REGENXBIO
Thomas Ciulla, MD, MBA
STOCK OWNERSHIP
Clearside Biomedical
EMPLOYMENT
Clearside Biomedical
Advertisement
Related to this article
GOLD leaders say COPD is diagnosed too late and its smoking-only image is outdated, and the 2027 report puts rehab and non-drug care up front.
Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was linked to worse outcomes.
Resmetirom real-world data at The Liver Meeting 2026 show 12-month gains in liver stiffness, fat, and enzymes among patients with MASH in 3 US data sets.
A study of 132 patients with AML given venetoclax-based therapy, 10 profiled by single-cell sequencing, linked immune features to treatment response.
This week in health equity and access: Medicaid cuts; mailed FIT outreach; EEOC pregnancy rules; GLP-1 Bridge access; and 2027 policy shifts.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
Clinicians at Population Health Roundtables shared obesity care innovations, from pharmacist-led models to same-day liver screening
Advertisement
Advertisement
Trending on AJMC
1
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
2
Medicaid Cuts and Caregiving in Congress: Andy Kim
3
GLP-1 RAs Improve MASLD, MASH Markers, but Long-Term Benefits Unclear
4
Health Equity & Access Weekly Roundup: November 6, 2026
5